Skip to main content

Cerity Partners LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1566475 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$19,040,248
+$69,210 QoQ
Shares Held
144,529
+8.1% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 4.437863681337309.ToString("F0")% Shared 34.18068346145064.ToString("F0")% None 61.38145285721205.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Cerity Partners LLC holds $73,705,978 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (25.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
144,529 $19,040,248

All Filings in NBIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $19,040,248 144,529
2025-12-31 $18,971,038 133,759
2025-09-30 $14,547,017 103,626
2025-06-30 $7,387,304 58,774
2025-03-31 $3,689,726 33,361
2024-12-31 $5,697,100 41,737
2024-09-30 $4,496,345 39,024
2024-06-30 $3,772,433 27,402
2024-03-31 $3,966,027 28,756
2023-12-31 $575,000 4,364
2023-06-30 $397,380 4,214
2023-03-31 $389,595 3,849
2022-12-31 $386,866 3,239
2022-09-30 $287,404 2,706
2022-06-30 $283,471 2,908